Suchergebnisse - "Kabamba-Mukadi, Benoît"

PubPharm (45)

21

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population : the experience of Belgium

enthalten in: BMC public health | 2019

von Lernout, T. | Kabamba-Mukadi, B. | Saegeman, V. | +6

22

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium

enthalten in: BMC public health | 2019

von Lernout, T. | Kabamba-Mukadi, B. | Saegeman, V. | +6

23

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium

enthalten in: BMC public health | 2019

von Lernout, T. | Kabamba-Mukadi, B. | Saegeman, V. | +6

24

Short Communication : An Insertion of Seven Amino Acids in the Envelope Cytoplasmic Tail of HIV-2 Selected During Disease Progression Enhances Viral Replication

enthalten in: AIDS research and human retroviruses | 2019

von Dufrasne, F. | Lucchetti, M. | Dessilly, G. | +3

25

Low hepatitis C prevalence in Belgium : implications for treatment reimbursement and scale up

enthalten in: BMC public health | 2019

von Litzroth, A. | Suin, V. | Wyndham-Thomas, C. | +8

26

Performance Evaluation of the MBT STAR®-Carba IVD Assay for the Detection of Carbapenemases With MALDI-TOF MS

enthalten in: Frontiers in microbiology | 2019

von Anantharajah, A. | Tossens, B. | Olive, N. | +3

27

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up

enthalten in: BMC public health | 2019

von Litzroth, A. | Suin, V. | Wyndham-Thomas, C. | +8

28

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up

enthalten in: BMC public health | 2019

von Litzroth, A. | Suin, V. | Wyndham-Thomas, C. | +8

29

Correction : First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium

enthalten in: PloS one | 2019

von Dessilly, G. | Goeminne, L. | Vandenbroucke, A. | +3

ErratumFor: PLoS One. 2018 Dec 31;13(12):e0209561. - PMID 30596682

30

First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium

enthalten in: PloS one | 2018

von Dessilly, G. | Goeminne, L. | Vandenbroucke, A. | +3

ErratumIn: PLoS One. 2019 Jan 25;14(1):e0211587. - PMID 30682153